Enclave Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$387K Buy
1,229
+15
+1% +$4.73K 0.05% 101
2026
Q1
$399K Buy
1,214
+34
+3% +$12.2K 0.05% 101
2025
Q4
$415K Buy
1,180
+126
+12% +$45.9K 0.06% 94
2025
Q3
$390K Hold
1,054
0.06% 88
2025
Q2
$417K Hold
1,054
0.07% 82
2025
Q1
$392K Hold
1,054
0.07% 81
2024
Q4
$380K Hold
1,054
0.06% 92
2024
Q3
$381K Buy
+1,054
New +$364K 0.06% 86

Other funds holding SYK

Enclave Advisors's SYK Position: Q2 2026 in Review

Enclave Advisors increased its Stryker (SYK) stake by 1.2% in Q2 2026, buying an estimated $4.73K and bringing the position to 1,229 shares worth $387K. The position accounts for 0.05% of the portfolio, ranked #101.

Enclave Advisors first reported a position in SYK in Q3 2024 and has held it in 8 quarters since. The position peaked at $417K in Q2 2025. 788 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Enclave Advisors held 1,229 shares of Stryker worth $387K as of Q2 2026.
  • Enclave Advisors bought 15 Stryker shares in Q2 2026, an estimated $4.73K.
  • Stryker made up 0.05% of Enclave Advisors's portfolio in Q2 2026, its #101 holding.
  • Enclave Advisors first reported a position in Stryker in Q3 2024 and has held it in 8 quarters since.
  • Enclave Advisors's Stryker position peaked at $417K in Q2 2025.
  • 788 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Enclave Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.